Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from RBC Capital Markets

Teladoc Analysts React To Shocking Q1 Losses, Rising BetterHelp Costs

A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance.

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

RBC Capital Markets views Tenet Healthcare Corp's (NYSE:THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds. The analysts have raised the price target from $89 to $104 (41% upside) with an Outperform rating. Against an increasingly difficult labor backdrop characterized by high agency utilization, Tenet could hold…

Why RBC Capital Upgrades Exxon Mobil, Downgrades Chevron

Why RBC Capital Upgrades Exxon Mobil, Downgrades Chevron

Exxon Mobil Corp (NYSE: XOM) is the largest oil company by market capitalization and the biggest of the “Super-Majors,” which includes Chevron Corporation (NYSE: CVX), according to RBC Capital Markets.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analysts Say Acadia's Negative Pain Data Increases Focus On Pimavanserin For Alzheimer's-Related Psychosis

Acadia Pharmaceuticals Inc (NASDAQ:ACAD) announced the primary endpoint miss of the phase 2 POC study of ACP-044 in acute postoperative pain following bunionectomy, a surgical procedure that moves toes back into the correct position. RBC Capital Markets writes that although trends of pain reduction were observed in the 400 mg QID ACP-044 arm compared…

Intuitive Surgical Has A 'Multi-Year Growth Runway,' RBC Capital Says: What Are The Catalysts?

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a global leader in the robotic-assisted surgery market, which is not only large — it is estimated at more than $6 billion — but also the most underpenetrated and fastest-growing among the medical device sub-markets, according to RBC Capital Markets.

Why RBC Is Turning Bullish On This Railroad

CSX Corporation’s (NASDAQ: CSX) stock has been under pressure due to its fourth-quarter results being less favorable than other companies in the industry, and its valuation has fallen “toward the lowest level relative to peers,” according to RBC Capital Markets.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bank of America

Intuitive Surgical

RBC Capital Markets

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play